Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing Transperineal Prostate Biopsy for Prostate Tissue Classification Algorithm Development

NCT03734575 is registered in ClinicalTrials.gov with Precision Biopsy, Inc. as lead sponsor.

NCT NCT03734575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03734575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing Transperineal Prostate Biopsy for Prostate Tissue Classification Algorithm Development
Lead sponsor
Precision Biopsy, Inc.
Phase
Not applicable
Overall status
Suspended
Start date
October 10, 2018
Completion date
July 9, 2019
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer